Suggested Readings

Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a Scientific Statement from the American Heart Association.

Feinstein MJ, Hsue PY, Benjamin LA, et al. Circulation. 2019;140(2):e98-e124.

Statin effect heterogeneity on plaque volume and composition in the REPRIEVE mechanistic substudy

Foldyna B, Zhou X, Mayrhofer T, et al. Presented at: CROI; March 9-12, 2025; San Francisco, California. Abstract 850.

Pitavastatin to prevent cardiovascular disease in HIV infection.

Grinspoon SK, Fitch KV, Zanni MV, et al. N Engl J Med. 2023;389(8):687-699.

Impact of semaglutide on weight change among people with HIV: a stratified analysis by baseline BMI.

Haidar L, Crane HM, Nance RM, et al. Presented at: CROI; March 3 – March 6, 2024; Denver, CO. Abstract 797.

Prevalence and characteristics of nonalcoholic fatty liver disease and fibrosis in people living with HIV monoinfection: a systematic review and meta-analysis.

Kalligeros M, Vassilopoulos A, Shehadeh F, et al. Clin Gastroenterol Hepatol. 2023;21(7):1708-1722.

Semaglutide reduces metabolic dysfunction-associated steatotic liver disease in people with HIV: SLIM LIVER.

Lake JE, Kitch DW, Kantor A, et al. Presented at: CROI; March 3-6, 2024; Denver, Colorado. Abstract 159.

Blood pressure increases are associated with weight gain and not antiretroviral regimen or kidney function: a secondary analysis from the ADVANCE trial in South Africa.

Manne-Goehler J, Fabian J, Sokhela S, et al. J Int AIDS Soc. 2024;27(7):e26268.

A multisociety Delphi consensus statement on new fatty liver disease nomenclature.

Rinella ME, Lazarus JV, Ratziu V, et al. Hepatology. 2023;78(6):1966-1986.

HIV and inflamm-aging: How do we reach the summit of healthy aging?

Sheets K, Baker JV. Top Antivir Med. 2024;32(5):589-596.

Social determinants of health and the hypertension care cascade in a national HIV cohort

Van Epps P, Musoke L, Harris N, et al. Presented at: CROI; March 9-12, 2025; San Francisco, California. Abstract 822.

Linked Resources

CLINICAL PRACTICE GUIDELINES

Standards of care in diabetes.

American Diabetes Association Professional Practice Committee. Diabetes Care. 2024;48(suppl 1).

BHIVA rapid guidance on the use of statins for primary prevention of cardiovascular disease in people living with HIV v2.

British HIV Association.

Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD practice guidance.

Chen VL, Morgan TR, Rotman Y, et al. Hepatology. 2025;81(1):312-320.

European AIDS Clinical Society (EACS) interim guidance on the use of statin therapy for the primary prevention of cardiovascular disease in people with HIV.

EACS.

Antiretroviral drugs for treatment and prevention of HIV in adults: 2024 recommendations of the International Antiviral Society-USA Panel.

Gandhi RT, Landovitz RJ, Sax PE, et al. JAMA. 2025;333(7):609-628

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Grundy SM, Stone NJ, Bailey AL, et al. Circulation. 2019;139(25):e1046-e1081.

2024 ESC guidelines for the management of elevated blood pressure and hypertension: developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO).

McEvoy JW, McCarthy CP, Bruno RM, et al. Eur Heart J. 2024;45(38):3912-4018.

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.

Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. Hepatology. 2023;77(5):1797-1835.

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults.

Whelton Paul K, Carey Robert M, Aronow Wilbert S, et al. J Am Coll Cardiol. 2018;71(19):e127-e248.

Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV.

US Department of Health and Human Services

CLINICIAN RESOURCES

Measure accurately: How well do you measure?

American Heart Association and American Medical Association

Clinical Guidelines Program: HIV Treatment

New York State Department of Health AIDS Institute

Clinician-to-Clinician Advice

National Clinician Consultation Center; University of California, San Francisco

Recommendations

US Preventive Services Task Force.

PATIENT AND CAREGIVER RESOURCES

AIDSMap

NAM Publications

Living with HIV

Centers for Disease Control and Prevention

Public HIV resources

National Institutes of Health

Clinician Pocket Guide

Related activities
 
1.00 CME/CE

Combating Common Cardiometabolic Comorbidities in Aging People with HIV

A Clinical Obstacles Challenge

Faculty: Laura Waters, MD, FRCP
Release: 04/01/2025
Expiration: 04/01/2026